Search clinical trials for: ABBV-368

Total 1405 results

Rush University Medical Center

Withdrawn

Comparison of Continuous and Burst High Frequency Spinal Cord Stimulation Paradigms

Chronic Low-back Pain | Peripheral Neuropathy | CRPS
Medical University of Graz

Completed

Prolonged Fasting on Glucose Metabolism and Hormonal Regulation in Healthy, Obese and Subjects With Type 2 Diabetes (PROLOG)

Healthy | Obesity | Type 2 Diabetes Mellitus | Type 1 Diabetes

Austria
LG Chem

Terminated

A Study of YVOIRE Y-Solution 360 for Hand Augmentation to Correct Volume Loss

Dorsal Hand Volume Loss

Korea, Republic of
Mati Therapeutics Inc.

Completed

An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear Lake

Dry Eye Syndromes

United States
Centocor, Inc.

Completed

A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease

Lymphoma, Non-Hodgkin | Multiple Myeloma | Giant Lymph Node Hyperplasia

United States
AbbVie

Completed

A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies

Cancer | Advanced Solid Tumors | Hematologic Malignancies

United States, Japan, Netherlands, Spain
AbbVie

Completed

A Study of ABT-165 in Subjects With Solid Tumors

Advanced Solid Tumors

United States
Y-mAbs Therapeutics

Terminated

Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers

Osteosarcoma | Neuroblastoma | Other Solid Tumor Cancers

United States
Atamyo Therapeutics

Recruiting

GNT0006 Gene Therapy Trial in Patients With LGMDR9

LGMDR9

Denmark, France, United Kingdom
Agios Pharmaceuticals, Inc.

Completed

A Phase I Study of AG-348 in Healthy Volunteers (AG-348 SAD)

Healthy Volunteer

United States
Zeria Pharmaceutical

Completed

The Effects of Z-338 in Subjects With and Without Functional Dyspepsia

Dyspepsia

Australia
Aalborg University Hospital

Recruiting

Treatment of Posterior Benign Paroxysmal Positional Vertigo With Mechanical Rotational Chair.

BPPV | Benign Paroxysmal Positional Vertigo

Denmark
Nektar Therapeutics
Eli Lilly and Company

Completed

A Study of NKTR-358 (LY3471851) in Healthy Participants

Healthy

United States
Instil Bio

Withdrawn

ITIL-168 in Advanced Solid Tumors (DELTA-2)

Cervical Cancer | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma
Meissa Vaccines, Inc.
Hvivo

Completed

Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine

RSV Infection

United Kingdom
National Institutes of Health Clinical Center (CC)
National Heart, Lung, and Blood Institute (NHLBI); Agios Pharmaceuticals, Inc.

Completed

A Dose-Finding Study of AG-348 in Sickle Cell Disease

Sickle Cell Disease

United States
National OncoVenture
Hanmi Pharmaceutical Company Limited

Completed

NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors (NSCLC)

Increased Drug Resistance

Korea, Republic of
University of Turin, Italy

Completed

Laparoscopic Total Fundoplication for Duodenogastroesophageal Reflux

Duodenogastric Reflux

Italy
Boryung Pharmaceutical Co., Ltd
Covance

Completed

Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects

Essential Hypertension
Holland Bloorview Kids Rehabilitation Hospital

Enrolling by invitation

A Virtual Dental Office Experience for Children With Autism Spectrum Disorder

Autism Spectrum Disorder

Canada
Nektar Therapeutics
Eli Lilly and Company

Terminated

A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC) (INSTRUCT-UC)

Colitis, Ulcerative

Australia, India, United States, Korea, Republic of, Hungary, United Kingdom, Japan, Argentina, Belgium, Brazil, Canada, China, Czechia, France, Georgia, Israel, Latvia, Poland, Romania, Russian Federation, Slovakia, Ukraine
Chonbuk National University Hospital

Completed

Effects of GS-3K8 and GINst15 on Acute Respiratory Illness

Acute Respiratory Infection

Korea, Republic of
National OncoVenture
Hanmi Pharmaceutical Company Limited

Terminated

NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma

Adenocarcinoma of Lung Stage IV | Adenocarcinoma of Lung Stage IIIB

Korea, Republic of
Southwest Oncology Group
National Cancer Institute (NCI)

Withdrawn

S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer

Kidney Cancer
Amgen

Completed

Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma

Gastrointestinal Cancer
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Tagraxofusp in Treating Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm After Stem Cell Transplant

Blastic Plasmacytoid Dendritic Cell Neoplasm

United States
Zeria Pharmaceutical

Completed

To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia

Functional Dyspepsia

Japan
AbbVie

Terminated

A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With Upadacitinib

Rheumatoid Arthritis (RA)

Belgium, Canada, Czechia, Hungary, Poland, Spain, United Kingdom
University of Oulu
Oulu University Hospital

Completed

Virtual 360°-Tour in Coronary Computed Tomography

Coronary Artery Disease | Anxiety | Fear

Finland
Chong Kun Dang Pharmaceutical

Completed

Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg

Type 2 Diabetes Mellitus

Korea, Republic of
Mercy Health Ohio
Stryker Neurovascular

Unknown

TARGET Intracranial Aneurysm Coiling Registry (TARGET)

Intracranial Aneurysms

United States
Zeria Pharmaceutical

Completed

Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment

Pancreatic Cancer

United Kingdom
Centocor, Inc.

Completed

A Study to Assess the Safety and Pharmacokinetics of a Single Intravenous Administration of CNTO 328 Derived From 2 Different Cell Lines in Healthy Participants

Healthy

United States
Gila Therapeutics, Inc.

Completed

A Dose Escalating Study to Assess the Safety and Tolerability of GT-001

Feeding and Eating Disorders

United States
Jagiellonian University

Recruiting

Quality of Life in Normogonadotropic Anovulation

Anovulation | Irregular Menses

Poland
AbbVie (prior sponsor, Abbott)

Completed

ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies

Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | B-cell Chronic Lymphocytic Leukemia | Myelodysplasia

United States
Zeria Pharmaceutical

Completed

To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia

Functional Dyspepsia

Belgium
University of Surrey

Completed

Acute Metabolic Effects of Carbohydrate Restriction at Varying Energy Levels

Healthy

United Kingdom
Zeria Pharmaceutical

Completed

Phase III, Long-term, Open-label Safety Study of Z-338

Dyspepsia

Belgium, Bulgaria, Latvia, Lithuania, Romania, Russian Federation, Slovakia, Sweden, Ukraine, United Kingdom
Zeria Pharmaceutical

Completed

To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia

Functional Dyspepsia

Japan
AbbVie
Boehringer Ingelheim

Completed

BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis
University of California, Davis

Withdrawn

Evaluation of Fracture Fixation With Energy and Cement in Tumors of the Spine (EFFECTS)

Spinal Fractures

United States
AbbVie

Completed

A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) (SLEek)

Systemic Lupus Erythematosus (SLE)

United States, Argentina, Australia, Bulgaria, Canada, China, Colombia, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Poland, Puerto Rico, Spain, Taiwan, United Kingdom
AbbVie
Boehringer Ingelheim

Completed

BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis
Zeria Pharmaceutical

Completed

The Effect of Z-338 in Subjects With Functional Dyspepsia

Functioanl Dyspepsia

Japan
Zeria Pharmaceutical

Completed

Z-360 Plus GEM in Subjects With Metastatic Pancreatic Adenocarcinoma (ZIPANG)

Metastatic Pancreatic Adenocarcinoma

Japan, Korea, Republic of, Taiwan
Assiut University

Not yet recruiting

Comparison Between Two Techniques of Subthreshold Diode Laser Cyclophotocoagulation in Refractory Glaucoma

Refractory Glaucoma
LG Chem

Terminated

To Evaluate the Performance and Safety of YVOIRE Y Solution 360 Versus Comparator for Lips and Perioral Area.

Lip Augmentation

Germany
Abbott
Abbott Japan Co.,Ltd

Completed

Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)

Hemodialysis | Secondary Hyperparathyroidism

Japan
Agios Pharmaceuticals, Inc.

Recruiting

A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Not Regularly Transfused, Followed by a 5-Year Extension Period (ACTIVATE-Kids)

Pediatric Pyruvate Kinase Deficiency | Pediatric Hemolytic Anemia

United States, Spain, Germany, Netherlands, Canada, France, Israel, Switzerland, Italy

Search clinical trials for: ABBV-368

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations